Founded in 2015, Sangui Bio is a Sydney-based life sciences company aiming to revolutionise how blood is analysed and used in medicine by shifting the focus to red blood cells (RBCs) and microsampling. We are creating powerful investigatory tools for a range of inflammatory conditions with an initial focus on cancer. Since its foundation, Sangui Bio has worked in collaboration with the Kolling Institute and Neoteryx.